Healthequity Inc (NASDAQ:HQY) – Stock analysts at KeyCorp lowered their Q4 2019 earnings per share (EPS) estimates for Healthequity in a report released on Tuesday, December 4th. KeyCorp analyst D. Hooker now expects that the company will earn $0.09 per share for the quarter, down from their previous estimate of $0.15. KeyCorp has a “Overweight” rating and a $105.00 price objective on the stock.
Healthequity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, December 4th. The company reported $0.22 EPS for the quarter, topping the Zacks’ consensus estimate of $0.20 by $0.02. The company had revenue of $70.50 million during the quarter, compared to the consensus estimate of $69.60 million. Healthequity had a net margin of 24.52% and a return on equity of 12.42%. Healthequity’s quarterly revenue was up 24.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.17 EPS.
Other equities analysts also recently issued research reports about the stock. Citigroup reiterated a “buy” rating and issued a $110.00 price target on shares of Healthequity in a report on Wednesday, September 5th. SunTrust Banks downgraded shares of Healthequity from a “buy” rating to a “hold” rating and cut their price target for the company from $105.00 to $90.00 in a report on Thursday. Cantor Fitzgerald increased their price objective on shares of Healthequity from $80.00 to $82.00 and gave the company a “neutral” rating in a research note on Thursday. BidaskClub cut shares of Healthequity from a “buy” rating to a “hold” rating in a research note on Friday. Finally, Raymond James increased their price objective on shares of Healthequity from $85.00 to $105.00 and gave the company an “outperform” rating in a research note on Monday, September 10th. Six research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $92.08.
Shares of HQY opened at $74.03 on Friday. The stock has a market capitalization of $5.19 billion, a PE ratio of 137.09, a P/E/G ratio of 2.90 and a beta of 1.37. Healthequity has a 52-week low of $42.92 and a 52-week high of $101.58.
Several institutional investors have recently added to or reduced their stakes in HQY. Acadian Asset Management LLC purchased a new stake in shares of Healthequity during the 2nd quarter valued at about $845,000. Eqis Capital Management Inc. purchased a new stake in shares of Healthequity during the 2nd quarter valued at about $422,000. Aperio Group LLC raised its position in shares of Healthequity by 6.3% during the 2nd quarter. Aperio Group LLC now owns 17,977 shares of the company’s stock valued at $1,350,000 after buying an additional 1,064 shares in the last quarter. Raymond James Financial Services Advisors Inc. raised its position in shares of Healthequity by 16.9% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 97,854 shares of the company’s stock valued at $7,349,000 after buying an additional 14,131 shares in the last quarter. Finally, Alps Advisors Inc. raised its position in shares of Healthequity by 26.8% during the 2nd quarter. Alps Advisors Inc. now owns 10,355 shares of the company’s stock valued at $483,000 after buying an additional 2,188 shares in the last quarter. 93.01% of the stock is currently owned by institutional investors.
In other Healthequity news, VP Darcy G. Mott sold 4,000 shares of the firm’s stock in a transaction dated Monday, October 22nd. The shares were sold at an average price of $87.01, for a total transaction of $348,040.00. Following the sale, the vice president now directly owns 92,500 shares of the company’s stock, valued at approximately $8,048,425. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Over the last three months, insiders sold 12,000 shares of company stock worth $1,027,400. 4.00% of the stock is owned by corporate insiders.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Story: Balance Sheet
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.